Be part of the knowledge.™

HDL - Predictor of CV risk and other roles

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Dr. Philip Barter, director of the Heart Research Institute in Sydney, Australia, shares some of his research on HDL. Not only is it an independent risk factor, even when LDL levels are very low, but it appears to have other roles in the body - including anti-inflammatory, anti-oxidant, and anti-thrombotic.

Philip Barter, MD, PhD

Philip Barter, MD, PhD

Gary Kohn, MD

Recommended

Details

Presenters

Overview
Dr. Philip Barter, director of the Heart Research Institute in Sydney, Australia, shares some of his research on HDL. Not only is it an independent risk factor, even when LDL levels are very low, but it appears to have other roles in the body - including anti-inflammatory, anti-oxidant, and anti-thrombotic.

Philip Barter, MD, PhD

Philip Barter, MD, PhD

Gary Kohn, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type

Perspectives with the AMA

Implementing the AMA MAPTM Hypertension Program: A Clinician’s Experience

The Heart’s Aftermath: IRI’s Impact on Cardiac Morbidity & Mortality

Biomarkers of the Storm: Decoding IRI’s Signature

Application of guidelines-recommended broad molecular profiling to patients with NSCLC

Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer

Impact of Barostim on Heart Failure Hospitalization

Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids